-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Therapy: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 2, 2018: 6:00 PM-8:00 PM
Hall GH (San Diego Convention Center)

Tim H. Brummendorf, MD1, Carlo Gambacorti-Passerini, MD2, Andreas Hochhaus, MD3, Jeff H. Lipton, MD, PhD4, Vamsi Kota, MBBS5, Michael W. Deininger, MD, PhD6, Eric Leip, PhD7*, Andrea Viqueira, MD8*, Roxanne Ferdinand, MBBS MFPM9* and Jorge E. Cortes, MD10

1Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Universitätsklinikum RWTH Aachen, Aachen, Germany
2School of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
3Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
4Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Winship Cancer Instiute of Emory University, Atlanta, GA
6Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT
7Pfizer Inc, Cambridge, MA
8Pfizer SLU, Madrid, Spain
9Pfizer Ltd, Walton-on-the-Hill, United Kingdom
10Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Giovanni Caocci, MD1*, Olga Mulas2*, Elisabetta Abruzzese3, Alessandra Iurlo4,5*, Imma Attolico, MD6*, Sara Galimberti7*, Luigia Luciano, MD8, Nicola Sgherza, MD9*, Massimiliano Bonifacio10*, Mario Annunziata11*, Antonella Gozzini, MD12*, Ester Maria Orlandi, MD13*, Fabio Stagno, MD, PhD14, Gianni Binotto, MD15*, Claudio Fozza, MD16*, Malgorzata Monika Trawinska, MD17*, Daniele Cattaneo, MD5*, Francesco Albano, MD18*, Claudia Baratè, MD, PhD19*, Fiorenza De Gregorio, MD8*, Luigi Scaffidi, MD20*, Chiara Elena, MD21*, Matteo Molica, MD22*, Giorgio La Nasa, MD2*, Robin Foà, MD23 and Massimo Breccia, MD24*

1Department of Medical Sciences and Public Health, University of Cagliari, "A.Businco" Hospital, Cagliari, Italy
2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
3Hematology, S.Eugenio Hospital, Roma, Italy
4Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
5Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
6University of Bari, Bari, Italy
7Hematology Department, University of Pisa, Pisa, Italy
8Hematology - Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
9Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
10Department of Medicine, Section of Haematology, Verona University, Verona, Italy
11Hematology, Ospedale Cardarelli, Napoli, Italy
12SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
13Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
14Hematology Unit, Hematology Section, Biomedical Sciences, Trecastagni, Catania, Italy
15Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, Italy
16Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
17Tor Vergata University, Hematology, S. Eugenio Hospital, Roma, ITA
18University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
19Department of Clinical and Experimental Medicine, Section of hematology, University of Pisa, Pisa, Italy
20Department of Medicine, Section of Hematology, Department of Hematology, University of Verona, Verona, Italy
21Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
22Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
23Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy
24Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy

Simone Claudiani, MD1,2*, Jane Apperley, MB ChB MD1,3, Afzal Khan2*, Richard Szydlo, PhD2*, George Nesr, MD1,2*, George Adams, MBChB1,2*, Letizia Foroni, MD, PhD4*, Jamshid S Khorashad, MD, PhD2,5* and Dragana Milojkovic, MBBS, PhD1*

1Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
2Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom
3Centre for Haematology, Imperial College London, London, United Kingdom
4Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
5Molecular Diagnostics, Imperial College Healthcare NHS Trust, London, United Kingdom

Hiroyuki Shimada, MD, PhD1*, Akihiko Tanizawa, MD, PhD2*, Takeshi Kondo, MD, PhD3, Hideki Muramatsu, MD, PhD4, Masahiro Yasui, MD5, Arinobu Tojo, MD, PhD6, Tokiko Nagamura-Inoue, MD, PhD7, Tetsuya Eto, MD, PhD8*, Aiko Igarashi, MD9*, Heiwa Kanamori, MD, PhD10, Maho Sato, MD5*, Maiko Noguchi, MD11*, Tatsuo Ichinohe, MD, PhD12, Masami Inoue, MD5, Koji Kato, MD, PhD13*, Yoshiko Atsuta, MD, PhD14* and Kazuteru Ohashi, MD, PhD9*

1Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan
2Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui, Japan
3Department of Hematology, Aiiku Hospital, Sapporo, Japan
4Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
5Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan
6Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
7Department of Cell Processing and Transfusion, IMSUT Cell Resource Center, Research Hospital,The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
8Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
9Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
10Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
11Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan
12Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
13Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
14The Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan

Abhishek Maiti, MBBS1,2, Hagop M. Kantarjian, MD3, Elias J. Jabbour, MD2, Rebecca Poku, MPH2*, Brittany A Yearby2*, Stephanie Breakefield, RN2*, Farhad Ravandi, MBBS2 and Jorge E. Cortes, MD2

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX

Jieun Uhm, MD, PhD1, Sung-Hyun Kim, MD, PhD2, Sukjoong Oh, MD, PhD3, Dae Young Zang, MD, PhD4*, Young Rok Do, PhD, MD5, Won Sik Lee, MD, PhD6, Myung Hee Chang, MD7*, Sung-Eun Lee, MD, PhD8* and Dong-Wook Kim, MD, PhD9,10

1Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea, Republic of (South)
2Department of Internal Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan, Korea, Republic of (South)
3Division of Hematology-Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea, Republic of (South)
4Department of Internal Medicine, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang-Si, Korea, Republic of (South)
5Department of Internal Medicine, Dongsan Medical Center Keimyung University, Daegu, Korea, Republic of (South)
6Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
7National Health Insurance Corp. Ilsan Hospital, Koyang, KOR
8Department of Hematology, Catholic Hematology Hospital, Seoul, Korea, Republic of (South)
9Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
10Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea

Lucia Masarova, MD1*, Jorge E. Cortes, MD1*, Keyur P. Patel, MBBS, PhD2, Susan M. O'Brien, MD3, Graciela M. Nogueras González, MPH4*, Marina Y. Konopleva, MD, PhD5, Srdan Verstovsek, MD, PhD1, Guillermo Garcia-Manero, MD6, Alessandra Ferrajoli, MD7, Tapan M. Kadia, MD8, Farhad Ravandi, MBBS1, Gautam Borthakur, MD1, Sara Emogene Dellasala, BS9*, Elias J. Jabbour, MD 10 and Hagop M. Kantarjian, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX
3UC Irvine, Chao Family Comprehensive Cancer Center, Orange, CA
4Biostatistics, UT MD Anderson Cancer Center, Houston
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
9UT MD Anderson Cancer Center, Houston, TX
10Deparmt, The University of Texas MD Anderson Cancer Center, Houston, TX

Simona Bernardi, PhD1,2*, Michele Malagola, MD3, Camilla Zanaglio, PhD1*, Alessandra Iurlo4*, Cristina Bucelli, MD5*, Nicola Polverelli, MD1*, Elif Dereli Eke, PhD Student6,7*, Massimiliano Bonifacio8*, Eleonora Toffoletti9*, Mario Tiribelli10*, Clara Deambrogi, PhD11*, Gianluca Gaidano, MD, PhD11, Stefania Stella, PhD12*, Fabio Stagno, MD, PhD13, Paolo Vigneri, MD, PhD14*, Francesco Di Raimondo, MD15*, Mirko Farina, MD1,16*, Mariella D'Adda16*, Doriana Gramegna, MD16*, Elisa Cerqui, MD16*, Giuseppe Rossi, MD16, Micaela Bergamaschi, MD17*, Marco Gobbi, MD18*, Luca Franceschini, M.D., PhD19*, Maria Teresa Voso19, Elisabetta Abruzzese20, Malgorzata Monika Trawinska, MD21* and Domenico Russo, MD1

1Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Chair of Hematology, Dpt of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
2Laboratorio CREA (Centro di Ricerca Emato-oncologica AIL), ASST Spedali Civili of Brescia, Brescia, Italy
3Cattedra di Ematologia, USD-TMO, University of Brescia-ASST Spedali Civili of Brescia, Brescia, ITA
4Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan, Milano, Italy
6Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
7CREA Lab, Spedali Civili of Brescia, Brescia, Italy
8Department of Medicine, Section of Haematology, Verona University, Verona, Italy
9Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
10Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
11Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
12Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
13Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
14Dep. Clinical and Experimental Medicine, University of Catania Medical School, Catania, Italy
15Divisione di Ematologia, Ospedale Ferrarotto, A.O.U. Policlinico-OVE, Università di Catania, Catania, Italy
16Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
17Division of Hematology, University of Genoa, Opsedale policlinico San Martino, IRCCS per l'Oncologia, Dipartment of Internal Medicine, Genova, Italy
18Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
19Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
20Hematology, S.Eugenio Hospital, Roma, Italy
21Tor Vergata University, Hematology, S. Eugenio Hospital, Roma, ITA

Mahesh Swaminathan, MD1*, Hagop M. Kantarjian, MD1, Koji Sasaki, MD1, Farhad Ravandi, MBBS2, Gautam Borthakur, MD1, Tapan M. Kadia, MD3, Guillermo Garcia-Manero, MD4, Courtney D. DiNardo, MD, MSc5, Marina Y. Konopleva, MD, PhD6, Zeev E. Estrov, MD1, Naveen Pemmaraju, MD1, Naval G. Daver, MD6, William G. Wierda, MD, PhD1, Alessandra Ferrajoli, MD7, Sherry A. Pierce, BSN, BA1*, MD Emogene Dellasala, BS8*, Elias J. Jabbour, MD 1 and Jorge E. Cortes, MD1*

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Franck Emmanuel Nicolini, MD, PhD1,2,3, Vincent Alcazer, MD2*, Pascale Cony-Makhoul, MD, PhD3,4*, Stephanie Dulucq, PhD3,5*, Sandrine Hayette, PhD3,6*, Isabelle Tigaud, MD6*, Liliana Villa, MD7*, Mohamad Sobh, PharmD2*, Stephane Morisset, Stat2*, Francois-Xavier Mahon, MD, PhD3,8 and Gabriel Etienne, MD, PhD3,9*

1INSERM U590, CRCL, Lyon, France
2Hematology, Centre Leon Berard, Lyon, France
3French group of CML (Fi-LMC), Pessac, France
4Centre Hospitalier Annecy-Genevois, Pringy, France
5Laboratory of Hematology, Hopital Haut Leveque, Pessac, France
6Laboratory of Hematology and molecular biology, CHU Lyon Sud, Pierre Benite, France
7Laboratory of Hematology, Groupement Hospitalier Est, Bron, France
8Hematology Department, Institut Bergonie, Bordeaux, France
9Hematology Department, Institut Bergonié, Bordeaux, France

Stephanie Foulon, MD1,2,3*, Pascale Cony-Makhoul, MD, PhD4*, Agnes Guerci-Bresler, MD, PhD5*, Marc Delord, PhD6*, Eric Solary, MD, PhD7, Alain Monnereau, MD, PhD8*, Julia Bonastre, PhD1,2* and Pascale Tubert Bitter, PhD3*

1Biostatistics Department, Gustave Roussy, Villejuif, France
2CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud Univ., Villejuif, France
3B2PHI Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, UVSQ, Institut Pasteur, Université Paris-Saclay, Villejuif, France
4Centre Hospitalier Annecy-Genevois, Pringy, France
5Service Hématologie, CHRU Brabois, Vandoeuvre, France
6Institut Universitaire d'Hématologie, Université Paris 7, Hôpital Saint Louis, Paris, France
7Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
8Registre des hémopathies malignes de la Gironde, Centre de Lutte Contre le Cancer, F-33076, Bordeaux, Réseau REPIH, Bordeaux, France

Tatsuro Jo, MD, PhD, Yohei Kaneko*, Kazuhiro Noguchi*, Shizuka Hayashi*, Risa Hayase*, Haruna Shioya*, Sadaharu Irie*, Kensuke Horio, MD* and Jun Taguchi, MD, PhD*

Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan

Dong-Wook Kim, MD, PhD1,2, Sung-Eun Lee, MD, PhD3*, Soo Young Choi4*, Dae Young Zang, MD, PhD5*, Won-Sik Lee6, Yeung-Chul Mun7*, Young Rok Do, PhD, MD8 and Sukjoong Oh, MD, PhD9

1Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea
2Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Leukemia Research Institute, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea
5Department of Internal Medicine, Hallym University College of Medicine, Hallym University Hospital, Anyang, Korea, Republic of (South)
6Department of Internal Medicine,, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea, Republic of (South)
7Department of Hematology, Ewha Womans University, Seoul, Korea, Republic of (South)
8Department of Internal Medicine, Dongsan Medical Center Keimyung University, Daegu, Korea, Republic of (South)
9Division of Hematology-Oncology, Kangbuk Samsung Hospital, Seoul, Korea, Republic of (South)

Carole Maute1*, Audrey Gauthier2*, Gwo-Jen Day, PhD3* and Jean-Michel Cayuela, PhD2,4*

1Laboratory of Hematology, University Hospital Saint-Louis, AP-HP, Paris & GBMHM External Quality Assessment platform, Pairs, France
2Laboratory of Hematology, University Hospital Saint-Louis, AP-HP, Paris & GBMHM External Quality Assessment platform, Paris, France
3Oncology R&D, Cepheid, Sunnyvale, CA
4EA 3518, University Paris 7, Paris, France

Hwang Wen-Li, MD1,2*, Shao-Min Han, MD1*, Shyuann-Yuh Lin, MD3*, Ming-Chih Chang, MD4*, Li-Yuan Bai, PhD5*, Pei-Ching Hsiao, MD6*, Ching-Yuan Kuo7*, Yeu-Chin Chen, MD8*, Ta-Chih Liu, MD, PhD9*, Po-Nan Wang, MD10, Jyh-Pyng Gau, MD11*, Yee-Ming Lee, PhD12*, Fan-Chen Ku12* and Jih-Luh Tang, MD13

1Taichung Veterans General Hospital, Taichung, Taiwan
2Asian University Hospital, Taichung, Taiwan
3Changhua Christian Hospital, Changhua, Taiwan
4MacKay Memorial Hospital, Taipei City, Taiwan
5Division of Hematology and Oncology, China Medical University Hospital, Taichung, Taiwan
6Chung Shan Medical University Hospital, Taichung, Taiwan
7Division of Hematology/Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
8Tri-Service General Hospital (TSGH), Taipei, Taiwan
9Kaohsiung Medical Univ. Hospital, Kaohsiung, Taiwan
10Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
11Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
12Novartis (Taiwan) Co. Ltd., Taipei, Taiwan
13Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Hawk Kim, MD, PhD1, Yunsuk Choi, MD2*, Sung-Soo Yoon, MD, PhD3, Won-Sik Lee4, Jee Hyun Kong, MD5*, Kyoo-Hyung Lee, MD, PhD6*, Jeong-Yeal Ahn, MD7* and Sang Kyun Sohn, MD, PhD8*

1Division of Hematology, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
2Department of Hematology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea, Republic of (South)
3Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
4Department of Internal Medicine,, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea, Republic of (South)
5Division of Hematology-oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
6Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
7Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
8Department of Hematology–Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)

Imma Attolico, MD1*, Roberto Latagliata2*, Massimo Breccia, MD3*, Elisabetta Abruzzese4, Alessandra Iurlo5*, Isabella Capodanno, MD6*, Mario Annunziata7*, Sara Galimberti8*, Mario Tiribelli9*, Bruno Martino, MD10*, Antonella Gozzini11*, Anna Rita Scortechini, MD12*, Chiara Elena, MD13*, Fausto Castagnetti14, Luigia Luciano, MD15, Carmen Fava16, Patrizia Pregno17*, Fabio Stagno, MD, PhD18, Micaela Bergamaschi, MD19*, Gianni Binotto, MD20*, Massimiliano Bonifacio21*, Giovanni Caocci, MD22*, Monica Crugnola, MD23*, Francesco Tarantini1*, Giorgina Specchia, MD1 and Francesco Albano, MD1*

1University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
2Department of Biotechnologies and cellular Hematology, Sapienza Università, Rome, Italy
3Division of Cellular Biotechnologies and Hematology, University "Sapienza", Roma, Italy
4Hematology Unit, S. Eugenio Hospital, Roma, Italy
5Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
6Azienda Unità Sanitaria Locale-IRCCS, Hematology Unit, Reggio Emilia, Italy
7Hematology, Ospedale Cardarelli, Napoli, Italy
8Hematology Department, University of Pisa, Pisa, Italy
9Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
10Haematology Dept.- Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
11Divisione di Ematologia-Policlinico Careggi di Firenze, Firenze, ITA
12Hematology Unit, A.O.U. Ospedali Riuniti, Ancona, Italy
13Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
14Institute of Hematology "L. e A. Seràgnoli", DIMES, University of Bologna, Bologna, Italy
15Hematology - Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
16Department of Clinical and Biological Science, University of Turin, Orbassano, Italy
17Hematology Unit, Az Ospedaliero Universitaria Città' della Salute e della Scienza, Torino, Italy
18Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
19Hematology Clinic, Policlinico San Martino-IST, Genova, Italy
20Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, Italy
21Department of Medicine, Section of Haematology, Verona University, Verona, Italy
22Department of Medical Sciences and Public Health, University of Cagliari, "A.Businco" Hospital, Cagliari, Italy
23Department of Medicine and Surgery, University of Parma, Parma, Italy

Aisling Nee, MB, Jeffrey H. Lipton, MD, PhD and Dennis Dong Hwan Kim, MD

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Anna Petrova, MD1*, Ekaterina Chelysheva, MD, PhD2*, Oleg Shukhov, MD, PhD2*, Anastasiya Bykova, MD2*, Galina Gusarova, MD, PhD2*, Irina Nemchenko, MD, PhD2*, Nikolay Tsyba, MD, PhD2*, Anna G Turkina, Prof., MD2, Tatiana Nikitina, PhD3,4*, Natalia Porfirieva3*, Anna Zinkovskaya3* and Tatiana Ionova, DSc4,5*

1National Research Center for Hematology, Moscow, Russia
2National Research Center for Hematology, Moscow, Russian Federation
3Multinational Center for Quality of Life Research, Saint-Petersburg, Russian Federation
4Clinic of High Medical Technologies named after N.I. Pirogov, Saint-Petersburg, Russian Federation
5University Clinic, St. Petersburg State University and Multinational Center for Quality of Life Research, Saint-Petersburg, Russian Federation

Frederic Picou, PhD1*, Jean-Claude Chomel, PharmD PhD2*, Marie Christine Bene, PharmD3*, Marc G. Berger, MD, PhD4,5*, Thierry Fest6*, Valerie Ugo, MD, PhD7, Eric Lippert, MD, PhD8*, Marion Socco-Luca9*, Martine Delain, MD10*, Marie-Helene Estienne, PharmD9* and Olivier Herault, MD, PhD11

1CNRS ERL 7001 LNOx "Leukemic Niche & Redox Metabolism", Tours, France
2Department of Biological Cancerology, University Hospital of Poitiers, Poitiers, France
3Department of Biological Hematology, University Hospital of Nantes, Nantes, France
4Department of Biological Hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France
5EA 7453 CHELTER, Clermont-Ferrand, France
6Department of Biological Hematology, University Hospital of Rennes, Rennes, France
7Laboratory of Hematology, University Hospital of Angers, Angers, France
8Department of Biological Hematology, University Hospital of Brest, Brest, France
9Department of Biological Hematology, University Hospital of Tours, Tours, France
10Department of Hematology and Cellular Therapy, University Hospital of Tours, Tours, France
11Dept of Biological Hematology, University Hospital of Tours, Tours, France

Aytug Kizilors, PhD1,2*, Patrick Harrington, FRCPath, MRCP2,3*, Sophie Jackson, BSc2*, Nicholas Lea, PhD4*, Joel Newman, MBBS, MRCP, BSc, FRCPath5*, Richard Gale, FRCPath, FRCP6*, Sandra Hassan, MD7*, Evangelia Dimitriadou, MD8*, Elena Crisà, MD9*, Luke Ficinski, BSc2*, Isabel Sa, BSc2*, Anita Arasaretnam, MD10*, Vijayavalli Dhanapal, MD11*, Timothy Corbett, FRCP, FRCPath10*, Robin M. Ireland, FRCP12, Antonio Pagliuca13,14, Ghulam J. Mufti12,15* and Hugues De Lavallade16,17*

1Haematology, Kings College London, LONDON, United Kingdom
2Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom
3King's College London, London, GBR
4King's College Hospital NHS Foundation Trust, London, GBR
5East Sussex Healthcare NHS Trust, Haematology, Eastbourne District General Hospital, Eastbourne, United Kingdom
6The Tunbridge Wells Hospital At Pembury, Tunbridge Wells, GBR
7Department of Haematology, Queen's Hospital, Romford, United Kingdom
8Haematology department, Maidstone Hospital, Maidstone, United Kingdom
9Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
10Haematology, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom
11Haematology, Medway Maritime Hospital, Gilligham, United Kingdom
12Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
13King's College Hospital, London, United Kingdom
14King’s College London, Molecular Haematology, Division of Cancer Studies, London, United Kingdom
15Department of Haemato-Oncology, King's College London, London, United Kingdom
16Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom
17Haematology department, King's College London, London, United Kingdom

Koji Sasaki, MD1, Hagop M. Kantarjian, MD2, Farhad Ravandi, MBBS1, Marina Y. Konopleva, MD, PhD1, Gautam Borthakur, MD1, Guillermo Garcia-Manero, MD2, William G. Wierda, MD, PhD2, Naval G. Daver, MD1, Alessandra Ferrajoli, MD1, Koichi Takahashi, MD3, Guillermo Montalban-Bravo, MD2*, Mary B. Rios, RN4*, Sherry A. Pierce, BSN, BA1*, Kenichi Sakurai, MD1*, Elias J. Jabbour, MD1 and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Deaprtment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH